
Haematology Consultant @CUH_NHS in acute leukaemia, myeloma, TYA, HSCT/cellular therapy. Views own.
Cambridge, England
Joined October 2011
- Tweets1.7K
- Following1.1K
- Followers556
- Likes1.3K
Andrew King retweeted
How does leukaemia develop? 🩸 How long does it take? ⏳
🌟 Our paper, started back when I was a PhD student in @jrblundell’s lab, is out today in @Nature 🌟
Yearly blood samples from women who developed AML in later life let us trace it back decades 👇
doi.org/10.1038/s41586-026-1…
Andrew King retweeted
You can now read our pre-print on developing a novel CAR T (RPG4) against mutated Calreticulin neoplasm #MPNsm
biorxiv.org/content/10.64898…
Many thanks to @darkwing179123 @drclaireroddie and @beth_psaila
and to our funders @The_MRC @bloodcancer_uk
More to follow!
Andrew King retweeted
If blood has clonal haematopoiesis… sperm should get clonal spermatopoiesis, right? 😉
Two great @Nature papers shed new light on how mutations drive clonal selection in sperm stem cells:
🧬 Neville et al. 👉 nature.com/articles/s41586-0…
👨👩👦 Seplyarskiy et al. 👉 nature.com/articles/s41586-0…
I had the privilege of writing the accompanying News & Views: 📝 rdcu.be/eL976 (Image © Nature)
Andrew King retweeted
The Naroditsky family shares the sad news of Daniel’s unexpected passing. Daniel was a talented chess player, educator, and beloved member of the chess community. We ask for privacy as the family grieves.
Andrew King retweeted
Arthur Ashe being half empty for Anisimova vs Osaka is so sad. Do you think it's cause it's just too late??
Andrew King retweeted
🚨🚨Paper out! 🚨🚨
Delighted to share our work, now published in @NatureGenet 🧬! shorturl.at/94s5S
We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n
🧵👇
Really interesting pragmatic paper which completely aligns with my experience - hypercalcaemia and MGUS very rarely due to progression to myeloma.
#Myeloma Paper of the Day: Insights from iStopMM study on hypercalcemia in setting of #MGUS indicate that most common causes were primary hyperparathyroidism (56.0%) and malignancies other than myeloma (16.0%) w/ only 3.2% being due to progression: pubmed.ncbi.nlm.nih.gov/3970…. #mmsm
1
2
634
Andrew King retweeted
How does clonal haematopoiesis evolve to leukaemia (AML)?🩸How long does it take?⏳
⭐️Excited to share our preprint!⭐️ Using serial blood samples collected BEFORE diagnosis of AML we unveil the somatic evolution📈 that occurs in the decades pre-diagnosis: biorxiv.org/content/10.1101/…
Andrew King retweeted
Please give generously in memory of Ellie and to help the inspirational Bray family raise money to #beatAML @bloodcancer_uk #AllforEllie
justgiving.com/team/teamelli…
Andrew King retweeted
“I’m immensely grateful for the funding I received from Cancer Research UK, which provided me with a key stepping stone in my clinician scientist career.”
@carolinewatson @EarlyCancerCam
📢 @CR_UK award us £9.2M to train future clinician scientists.
👉 crukcambridgecentre.org.uk/n…
Andrew King retweeted
📢🌟Join us in the Watson Lab @EarlyCancerCam @Cambridge_Uni ! We’re seeking an enthusiastic postdoc to delve into factors shaping pre-leukemic evolution in blood 🧬🩸 and lead development of remote monitoring methods. Please RT! 🙂 Apply now!👉 jobs.cam.ac.uk/job/45306/
Andrew King retweeted
💫ONLINE NOW @NatureCancer – the #2023Generation – 12 group leaders share their journey to becoming an independent PI. Very inspiring stories, please do not miss them!
nature.com/articles/s43018-0…
Andrew King retweeted
📢Clonal hematopoiesis driven by mCAs📢What fitness effects do mCAs confer to our blood cells?🩸 How often do they occur? Does an mCA’s fitness correlate with blood cancer risk?🔎Read mine & @jrblundell's latest paper @NatureGenet to find out (& more!):👉🔗rdcu.be/dlRRr
Andrew King retweeted
Can cancer be detected earlier by employing wearable technologies?
📢 Call for abstracts! Researchers from academia and industry are invited to submit abstracts for our workshop @Cambridge_Uni on 20th Oct 2023.
⏰Deadline for abstracts: 6th Sept 2023.
👉🔗bit.ly/wearables-cancer-dete…
Andrew King retweeted
👏Delighted to announce the appointment of two junior group leaders to @EarlyCancerCam.
@carolinewatson researches clonal haematopoiesis, MDS, AML & blood cancer evolution. @AFrankell will develop high sensitivity technologies to detect and track cancer.
Congratulations!
Andrew King retweeted
Delighted to share our new approach for high fidelity sc genotyping combined with scATAC - called GTAC! Do check it out! We love it. Great collaboration with the Hughes and Davies labs also in the WIMM. Credit to Sven, Asger, Angus and all co-authors.
cell.com/cell-stem-cell/full…
Andrew King retweeted
🍾🍾Huge congratulations to @carolinewatson, @CR_UK clinical research fellow, who has been awarded the prestigious Milo Keynes award for her outstanding PhD thesis. Very will deserved!
@jrblundell lab
earlycancer.cam.ac.uk/news/c…
Andrew King retweeted
Words cannot express the feelings of all at LPT to describe Ellie Bray and her astonishing kindness.
Before she tragically passed away last month, she asked to leave £5,000 to LPT to help others with hair loss.
To read more on this amazing young woman, see ow.ly/mOLY50KarSJ
Andrew King retweeted
Preliminary results from a phase 1/2 trial with 18 months follow up show that transplantation of #CRISPR/Cas9 BCL11A-edited autologous #hematopoietic cells in two pediatric patients with #BetaThalassemia was safe and achieved transfusion independence.
nature.com/articles/s41591-0…
Andrew King retweeted
🚨Job Alert🚨 We’re hiring a postdoc to work on genetic diseases of chromatin! 🧬
🏫Come work with us at @HumanGeneticsOx in the beautiful @UniofOxford
🗓Closing 6 July
📨 More details at beagrielab.com/join
Pls share and RT!
#PostdocJobs #GeneticsJobs #genomics #cohesin





























